How genome editing could be used in the treatment of cardiovascular diseases K Musunuru Volume 15 (Issue 2) [2] 2 The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs GM Oderda, GD Lawless, GC Wright, et al. Volume 15 (Issue 4) [3] 3 Wearables and the medical revolution J Dunn, R Runge, M Snyder Volume 15 (Issue 5) [4] 4 'Your DNA, Your Say': global survey gathering attitudes toward genomics: design, delivery and methods A Middleton, E Niemiec, B Prainsack, et al. Volume 15 (Issue 4) [5] 5 Analytical validation of a psychiatric pharmacogenomic test